4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Shilpa Medicare Limited (SHILPAMED) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Raichur, India with about 1,241 employees. Its market capitalization is roughly ₹200 billion. In the fiscal year ended 2026-03-31, SHILPAMED reported ₹15.4B in revenue and ₹2.4B in net income.
Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹15.4B | ₹12.8B | ₹11.5B | ₹10.4B | — |
| Gross Profit | ₹10.8B | ₹8.7B | ₹7.4B | ₹6.3B | — |
| Operating Income (EBIT) | ₹2.7B | ₹2.0B | ₹1.3B | (₹46M) | — |
| Net Income | ₹2.4B | ₹783M | ₹319M | (₹325M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹4.7B | ₹4.4B | ₹4.1B | ₹3.7B | ₹3.2B | — |
| Gross Profit | ₹3.3B | ₹3.0B | ₹2.8B | ₹2.6B | ₹2.4B | — |
| Operating Income (EBIT) | ₹1.0B | ₹1.1B | ₹839M | ₹785M | ₹627M | — |
| Net Income | ₹1.0B | ₹1.1B | ₹446M | ₹441M | ₹469M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹98M) | — | — | (₹96M) | (₹90M) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹37.1B | ₹33.1B | ₹30.9B | ₹29.0B | — |
| Total Liabilities | ₹11.1B | ₹9.5B | ₹12.9B | ₹11.3B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SHILPAMED viewer.
About TickerBase · Data methodology & sources · Privacy · Terms